J JS Lee RTW Spring 2019 Image Credit: Giovanni Giannoni/WWD . J JS Lee RTW Spring 2019. J JS Lee RTW Spring 2019 Image Credit: Giovanni Giannoni/WWD . J JS Lee RTW Spring 2019. J ...
J JS Lee RTW Fall 2015 J JS Lee RTW Fall 2015 Image Credit: Giovanni Giannoni J JS Lee RTW Fall 2015 J JS Lee RTW Fall 2015 Image Credit: Giovanni Giannoni J JS Lee RTW Fall 2015 J JS Lee RTW Fall ...
Zacks.com on MSN
J&J's Q4 Earnings Beat, Stock Down on Tepid 2025 Sales Guidance
Johnson & Johnson’s JNJ fourth-quarter 2024 earnings came in at $2.04 per share, which beat the Zacks Consensus Estimate of ...
People who got the "one-and-done" Johnson & Johnson COVID-19 vaccine may feel forgotten in the booster debate. There aren't immediate plans for a J&J booster, but some doctors think there should be.
Johnson & Johnson JNJ has a strong R&D pipeline, with primary focus areas being immunology, oncology and neuroscience. J&J rapidly advanced its pipeline in 2025, attaining significant clinical and ...
Economic turnaround hopes are strongly tied to the vaccine rollout around the globe — so a new concern over the Johnson & Johnson Covid-19 vaccine was just about the last thing the recovery needed. US ...
A new legal setback for Johnson & Johnson (JNJ) could make it more difficult for 3M (MMM) and other big companies to use a controversial bankruptcy tactic to shed costly product-liability lawsuits. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results